1
|
Agbanglanon DP, Jaba S, Kietga GG, M’barki I, Elkacemi H, Kebdani T, Elmajjaoui S, Benjaafar N. Verrucous Carcinoma of the Vulva. Tumori 2021. [DOI: 10.1177/03008916211012337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Introduction: Vulvar verrucous carcinoma (VC) is extremely rare, accounting for less than 1% of vulvar cancer cases. Effectively, it is characterization by a slow growing, no metastasis or lymph node involvement. The aim of this study was to report our experience with this disease Material and Methods: This is a retrospective study of patients with vulvar VC who were treated at National Institute of Oncology between 2013 and 2018. Clinicopathological characteristics, treatment and follow-up were extracted from the medical records. Results: Three cases were identified in the National Institut of Oncology. The average age at diagnosis was 66 years (± 10.02). The average time from the onset of symptoms to diagnosis was 17 months (± 12,7). All patients complained of a vulvar mass or nodule, accompanied by vulvar pruritus and/or pain, which was the reason for consultation. A preliminary pathological diagnosis of squamous cell carcinoma was made in two cases. Surgical treatment included wide local excision, radical vulvectomy with lymph node dissection in the groin. Tumor size and invasion depth ranged from 50 to 105 mm and 17 to 35 mm respectively. In the final histology, VC of the vulva staged IB (2 cases) and staged III (1 case) with marginal limits in two cases. The concurrent radiochemotherapy was performed in one case, exclusive radiotherapy in one case and only surgery in one case. Regarding toxicity after concurrent radiochemotherapy and exclusive radiotherapy we had observed respectely grade 2 proctitis with renal toxicity and grade 2 radiodermatitis. The mean follow-up was 43 months with no recurrence in all cases. The prognosis is good, with low recurrent rate if wide local excision is performed. Conclusions: Vulvar VC is a distinct type of slow-growing, tumor with unclear etiology. Surgery is the most effective treatment. Concurrent radiochemotherapy indicated depending on disease stage and risk factors.
Collapse
Affiliation(s)
- DP Agbanglanon
- Department of Radiotherapy, National Institute of Oncology, Mohammed V University of Rabat, Rabat, Morocco
| | - S Jaba
- Department of Radiotherapy, National Institute of Oncology, Mohammed V University of Rabat, Rabat, Morocco
| | - GG Kietga
- Department of Radiotherapy, National Institute of Oncology, Mohammed V University of Rabat, Rabat, Morocco
| | - I M’barki
- Department of Radiotherapy, National Institute of Oncology, Mohammed V University of Rabat, Rabat, Morocco
| | - H Elkacemi
- Department of Radiotherapy, National Institute of Oncology, Mohammed V University of Rabat, Rabat, Morocco
| | - T Kebdani
- Department of Radiotherapy, National Institute of Oncology, Mohammed V University of Rabat, Rabat, Morocco
| | - S Elmajjaoui
- Department of Radiotherapy, National Institute of Oncology, Mohammed V University of Rabat, Rabat, Morocco
| | - N Benjaafar
- Department of Radiotherapy, National Institute of Oncology, Mohammed V University of Rabat, Rabat, Morocco
| |
Collapse
|
2
|
Touimi SH, N’chiepo D, Mbarki I, Elkacemi H, Elmajjaoui S, Kebdani T, Benjaafar N, Neftah C, Saoud A, Boulaarab J, Jerguigue H, Omor Y, Latib R, El Agouri H, El Khannoussi B. Apocrine Carcinoma of Breast in a Male Patient: Case Report. Tumori 2020. [DOI: 10.1177/0300891620914132] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Introduction: Apocrine carcinoma of breast is a rare type of malignant tumor, the incidence of which varies between 0.3 - 0.4 % of all female breast cancers.Apocrine carcinoma is exceptional in male patients and very few cases have been described in literature. This tumor shows distinct microscopic and immunohistological features. We report an exceptional observation of apocrine carcinoma of breast in a man. Patient and observation: He’s a 54 years old man who had for 2months a painless nodule at the left axillary..The patient had family history of breast and prostate cancers. Physical examination revealed a left axilary lymphadenopathy movable relative to superficial and deep plans with no evidence mass of breasts. MRI of the breast was performed and revealed a mass that was 38 x 10 mm in size.A biopsy of the lymphadenopathy was performed. It objectified a carcinomatous proliferation. An immunohistochemical study showed that tumor cells express Her 2, but do not express estrogenic and progesterone receptors. A tumorectomy of the left breast was performed and didn’t show any malignant lesion of the breast. The axiler dissection of 13 lymphnodes showed 11 metastatics ones with 3 breaking capsular. The diagnosis of apocrine carcinoma of the breast was made in despite of the result of the tumorectomy. The CT did not indicate metastasis. The patient was administered adjuvant chemotherapy then he received radiation therapy on left susclavicular, axila and breast with a total dose of 42Gy,15 fractions of 2.8 Gy on 21 days with no late effects. 1 year of trastuzumab was administrated. There was no recurrence or metastasis approximately 2 years after radiation therapy. Then the patient presented a susclavicular lymphnode that was comfirmed on the pet-scanner with multiple mediastinal lymphnodes. A biopsy of the susclavicular lymphnode comfirmed the progression of the disease. The patient started chemotherapy in association with pertuzumab and trastuzumab. Discussion: Apocrine carcinoma of the breast is a rare malignant tumor whose incidence varies between 0.3% and 4% of all female’s breast cancer and represents 0.5 % of all invasive breast cancers. This tumor is exceptional in men. Indeed, only a dozen cases have been described in the literature . Most neoplasms are slowly progressive, small in size, and are most frequently seen in the axilla. They can be recurrent and metastasize to the lymph node, lung, and bone. Male patients have been advanced disease at presentation compared to women which may be due to lack of public awareness of breast cancer in male. Histologically, it has glandular structures with apocrine features and decapitation secretions. There is cytoplasmic PAS positivity of the tumor cells. The presence of neoplastic glands high in the dermis and immediate subepidermis favors the primary origin of tumor cells from apocrine sweat glands. Apocrine adenocarcinomas are positive for cytokeratins, carcinoembryogenic antigen (CEA) and epithelial membrane antigen (EMA) . Usually, these tumors do not express the estrogen receptor-alpha, progesterone receptors and bcl-2. Apocrine adenocarcinoma has poor prognosis and the prognostic factors include size, histological type, lymph node involvement, and distant metastasis. The 10-year disease free survival rate in the absence of metastasis to the lymph nodes is 56%. Treatment protocols of apocrine carcinoma are similar to non apocrine carcinoma of breast. However studies involving the use of anti androgens are in progress. The treatment of choice is wide local excision with clear margins, with or without regional lymph node dissection. The role of radiation therapy also remains uncertain in the absence of clinical trials. No clear correlation between treatment modality and recurrence in apocrine carcinoma was apparent, and survival rates of apocrine carcinoma were not different from other breast carcinomas. Conclusion: In conclusion, male apocrine carcinoma is a very rare, unique and morphologically-distinctive, invasive ductal carcinoma.. Although immunohistochemical staining might show differences in males, the prognosis is not different from other breast carcinomas. It has different hormonal profile, androgen receptor positivity makes patient with apocrine carcinoma eligible for targeted therapy.
Collapse
Affiliation(s)
- S. H Touimi
- Department of Radiation Oncology, Institut national d’oncologie de Rabat, Maroc
| | - D N’chiepo
- Department of Radiation Oncology, Institut national d’oncologie de Rabat, Maroc
| | - I Mbarki
- Department of Radiation Oncology, Institut national d’oncologie de Rabat, Maroc
| | - H Elkacemi
- Department of Radiation Oncology, Institut national d’oncologie de Rabat, Maroc
| | - S Elmajjaoui
- Department of Radiation Oncology, Institut national d’oncologie de Rabat, Maroc
| | - T Kebdani
- Department of Radiation Oncology, Institut national d’oncologie de Rabat, Maroc
| | - N Benjaafar
- Department of Radiation Oncology, Institut national d’oncologie de Rabat, Maroc
| | - C Neftah
- Department of Radiology, Institut national d’oncologie de Rabat, Maroc
| | - A Saoud
- Department of Radiology, Institut national d’oncologie de Rabat, Maroc
| | - J Boulaarab
- Department of Radiology, Institut national d’oncologie de Rabat, Maroc
| | - H Jerguigue
- Department of Radiology, Institut national d’oncologie de Rabat, Maroc
| | - Y Omor
- Department of Radiology, Institut national d’oncologie de Rabat, Maroc
| | - R Latib
- Department of Radiology, Institut national d’oncologie de Rabat, Maroc
| | - H El Agouri
- Department of Pathology, Institut national d’oncologie de Rabat, Maroc
| | - B El Khannoussi
- Department of Pathology, Institut national d’oncologie de Rabat, Maroc
| |
Collapse
|
3
|
Semmar A, EL Majjaoui S, EL Kacemi H, Kebdani T, Benjaafar N. Patient satisfaction in Ambulatory Radiochemotherapy: a study based on the Out-Patsat35 questionnaire. Tumori 2020. [DOI: 10.1177/0300891620914123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Objective: The aim of our study is to define the main factors contributing to the satisfaction of patients undergoing radiochemotherapy in outpatient setting. Materials and Methods: 100 Patients undergoing ambulatory concomitant radiochemotherapy in National Institute of Oncology at Rabat in Morocco were invited to complete the OUT-PATSAT35 questionnaire, evaluating perception of doctors, nurses and aspects of care organization, translated on Arabic language. The data were collected from different patients, over a period of three months. Statistical analysis was performed to determine which parameters had the greatest influence on overall satisfaction. Results: Overall satisfaction with the provided care was high with a mean satisfaction score of 3.19. Significant correlations were found between overall satisfaction and each of the following survey items: professional skills provided by doctors, behavior of doctors towards patients (patients support), behaviors of nurses towards patients, human qualities of nurses (politeness, respect, kindness and patience), care information provided by nurses, waiting time to get a medical consultation appointment, speed of execution of radiological examination and treatment and service organization. Linear regression analysis demonstrated that service organization, behavior of doctors and nurses towards patients, and care information provided by nurses were the strongest predictors for overall satisfaction, followed by waiting time to get a medical consultation appointment, speed of execution of radiological examination and treatment. Conclusion: Our study shows that the majority of our patients are satisfied with the level of our service, but the waiting time to get a medical consultation appointment, and speed of execution of radiological examination and treatment needs to be developed.
Collapse
Affiliation(s)
- A. Semmar
- Department of radiotherapy, National Institute of Oncology, University Mohammed V, Rabat,Morocco
| | - S. EL Majjaoui
- Department of radiotherapy, National Institute of Oncology, University Mohammed V, Rabat,Morocco
| | - H. EL Kacemi
- Department of radiotherapy, National Institute of Oncology, University Mohammed V, Rabat,Morocco
| | - T. Kebdani
- Department of radiotherapy, National Institute of Oncology, University Mohammed V, Rabat,Morocco
| | - N. Benjaafar
- Department of radiotherapy, National Institute of Oncology, University Mohammed V, Rabat,Morocco
| |
Collapse
|
4
|
Neftah C, Saoud A, Jerguigue H, Latib R, Omor Y, Touimi S, Mbarki I, Jaba S, Elkacemi H, Elmajjaoui S, Kebdani T, Benjaafar N. Apport de l’IRM dans le bilan pré- et post-thérapeutique des cancers du cavum. J Neuroradiol 2020. [DOI: 10.1016/j.neurad.2020.01.058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
5
|
Neftah C, Saoud A, Jerguigue H, Latib R, Omor Y, Touimi S, Mbarki I, Jaba S, Elkacemi H, Elmajjaoui S, Kebdani T, Benjaafar N. Place de l’IRM dans les complications neurologiques de la radiothérapie. J Neuroradiol 2020. [DOI: 10.1016/j.neurad.2020.01.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
6
|
Jaba S, Touimi SH, Elkacemi H, Elmajjaoui S, Kebdani T, Benjaafar N, Neftah C, Latib R, Omor Y. Les toxicités neurologiques tardives après irradiation des tumeurs de la sphère ORL : intérêt de l’IRM. J Neuroradiol 2020. [DOI: 10.1016/j.neurad.2020.01.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Jaba S, Touimi SH, Elkacemi H, Elmajjaoui S, Kebdani T, Benjaafar N, Neftah C, Latib R, Omor Y. Apport de l’imagerie dans le diagnostic et le suivi post-thérapeutique des rhabdomyosarcome de la fosse infra-temporale chez l’adulte. J Neuroradiol 2020. [DOI: 10.1016/j.neurad.2020.01.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
8
|
Saoud A, Neftah C, Boulaarab J, Jerguigue H, Omor Y, Latib R, Touimi S, Jaba S, Mbarki I, Elkacemi H, Elmajjaoui S, Kebdani T, Benjaafar N. Germinome pinéal : à propos de deux cas. J Neuroradiol 2020. [DOI: 10.1016/j.neurad.2020.01.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
9
|
Jaba S, Touimi SH, Elkacemi H, Elmajjaoui S, Kebdani T, Benjaafar N, Neftah C, Latib R, Omor Y. Apport de l’imagerie dans les paragangliomes endocrâniens. J Neuroradiol 2020. [DOI: 10.1016/j.neurad.2020.01.066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
10
|
Jaba S, Touimi SH, Elkacemi H, Elmajjaoui S, Kebdani T, Benjaafar N, Neftah C, Latib R, Omor Y. Place de l’imagerie dans le bilan initial et l’évaluation de la réponse thérapeutique du mélanome muqueux de la fosse nasale. J Neuroradiol 2020. [DOI: 10.1016/j.neurad.2020.01.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
11
|
Hommadi M, Houessou O, Mbarki I, Aboulkacem M, Boutayeb S, Bakkali H, Benjaafar N. Curiethérapie de contact de haut débit de dose pour les cancers cutanés avec l’applicateur FLAP : à propos de huit cas. Cancer Radiother 2019. [DOI: 10.1016/j.canrad.2019.07.111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
12
|
Nourreddine A, Marnouche E, Krabch MA, moursli RE, Benjaafar N. 23 Vulvar cancer: Comparative study of novel 3D radiation therapy technique “ Advanced conformal technique ” and AP-PA irradiation techniques. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.09.105] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
13
|
Aarab J, Allam A, Sfaoua H, Lahlali F, Moukasse Y, El Majjaoui S, Kebdani T, El Kacemi H, Benjaafar N. Étude des mouvements entre les fractions de la prostate par tomographie conique chez les patients pris en charge par arcthérapie volumétrique modulée pour un cancer de la prostate : expérience de l’Institut national d’oncologie de Rabat. Cancer Radiother 2018. [DOI: 10.1016/j.canrad.2018.07.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
14
|
Lachgar A, Sahli N, Benjaafar N. [Pain flare following palliative external beam radiotherapy: Prospective study of 41 cases]. Cancer Radiother 2017; 21:373-376. [PMID: 28532618 DOI: 10.1016/j.canrad.2017.01.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2016] [Revised: 01/15/2017] [Accepted: 01/17/2017] [Indexed: 11/16/2022]
Abstract
PURPOSE Radiotherapy plays a major role in relieving pain caused by bone metastases; paradoxically initial flare of symptom is common. Our objectives were to assess prospectively the incidence, and to identify predictor's factors of this acute complication. PATIENT AND METHODS Forty-one patients treated with analgesic external beam radiotherapy were followed prospectively. Patients recorded pain severity and analgesic intake was documented. Pain flare was defined as an increase of two points in the intensity of pain on the numerical scale with no reduction in analgesic intake and/or 25% increase of the analgesic intake without decreasing pain intensity. RESULTS Primary cancer was the breast, lung and prostate in 49%, 29% and 22% of patients respectively. Twelve patients (29%) had a pain flare. No factor was significantly associated with the occurrence of this complication. A favorable analgesic response was observed in 27 patients. The pain flare was not related to subsequent analgesic response. CONCLUSION Radiotherapy is an effective treatment of pain related to bone metastasis, but with a high incidence of painful exacerbation.
Collapse
Affiliation(s)
- A Lachgar
- Centre régional d'oncologie, hôpital Mohamed-V, avenue carabonita, 32000 Al Hoceima, Maroc.
| | - N Sahli
- Service de radiothérapie, Institut national d'oncologie, avenue Alla-Fassi-Hay-Ryad, 10000 Rabat, Maroc
| | - N Benjaafar
- Service de radiothérapie, Institut national d'oncologie, avenue Alla-Fassi-Hay-Ryad, 10000 Rabat, Maroc
| |
Collapse
|
15
|
Lachgar A, Tazi M, Afif M, Er-Raki A, Kebdani T, Benjaafar N. Lung cancer: Incidence and survival in Rabat, Morocco. Rev Epidemiol Sante Publique 2016; 64:391-395. [DOI: 10.1016/j.respe.2016.02.012] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2015] [Revised: 01/03/2016] [Accepted: 02/02/2016] [Indexed: 11/24/2022] Open
|
16
|
Berhili S, Kadiri S, Benoulaid M, Aissa A, Ogandaga E, El Majjaoui S, Elkacemi H, Kebdani T, Benjaafar N. Quelle est la valeur du soutien familial dans la survenue de la détresse psychologique chez les patientes suivies pour cancer du sein ? Cancer Radiother 2016. [DOI: 10.1016/j.canrad.2016.08.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
17
|
Aarab J, Sfaoua H, Allam A, Lahlali F, Moukasse Y, Benhmidou N, Elmajjaoui S, Elkacemi H, Kebdani T, Benjaafar N. Radiothérapie hypofractionnée du cancer du sein avec envahissement ganglionnaire massif : résultats thérapeutiques et toxicité. Cancer Radiother 2016. [DOI: 10.1016/j.canrad.2016.08.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
18
|
Sahli N, Khmou M, Khalil J, Elmajjaoui S, El Khannoussi B, Kebdani T, Elkacemi H, Benjaafar N. Unusual evolution of leiomyosarcoma of the rectum: a case report and review of the literature. J Med Case Rep 2016; 10:249. [PMID: 27633779 PMCID: PMC5025574 DOI: 10.1186/s13256-016-1047-8] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2016] [Accepted: 08/29/2016] [Indexed: 01/01/2023] Open
Abstract
Background Leiomyosarcoma of the rectum is a rare entity that comprises less than 0.1 % of all rectal malignancies. Given the uncommon nature of this tumor and the controversy about its treatment we report one case and review the literature in an attempt to report a particular evolution and to discuss the most appropriate treatment. Case presentation This case report describes the presentation of leiomyosarcoma of the rectum. A 30-year-old man from the north of Morocco presented with rectorrhagia and constipation. On physical examination we found a mass in his rectum approximately 6 cm from his anal margin. Pelvic magnetic resonance imaging showed a rectal mass with a parietal attachment that invaded the fascia and his perirectal tissue. Before any treatment he defecated spontaneously the tumor. On histopathological examination a diagnosis of leiomyosarcoma was made. An anterior resection of his rectum was performed with adjuvant radiotherapy at a dose of 50 Gy. After 1 year of surveillance, he has not presented any clinical symptoms and pelvic magnetic resonance imaging was normal. Unfortunately, histological analysis of a superficial biopsy of a rectal leiomyosarcoma may not be reflective of the entire tumor mass, and a diagnosis is based essentially on postoperative pathological examination. The optimal treatment modality in patients with rectal leiomyosarcomas is controversial. Prognosis is also poor; tumor size, histological grade, mitotic index, and local staging are the most known prognosis factors. Conclusion The prognosis of rectal leiomyosarcoma is poor; more investigations are necessary to understand the progression of these tumors and to define an optimal treatment modality.
Collapse
Affiliation(s)
- N Sahli
- Department of Radiotherapy, National Institute of Oncology, University Mohammed V, Rabat, Morocco.
| | - M Khmou
- Department of Pathology, National Institute of Oncology, University Mohammed V, Rabat, Morocco
| | - J Khalil
- Department of Radiotherapy, National Institute of Oncology, University Mohammed V, Rabat, Morocco
| | - S Elmajjaoui
- Department of Radiotherapy, National Institute of Oncology, University Mohammed V, Rabat, Morocco
| | - B El Khannoussi
- Department of Pathology, National Institute of Oncology, University Mohammed V, Rabat, Morocco
| | - T Kebdani
- Department of Radiotherapy, National Institute of Oncology, University Mohammed V, Rabat, Morocco
| | - H Elkacemi
- Department of Radiotherapy, National Institute of Oncology, University Mohammed V, Rabat, Morocco
| | - N Benjaafar
- Department of Radiotherapy, National Institute of Oncology, University Mohammed V, Rabat, Morocco
| |
Collapse
|
19
|
Maghous A, Rais F, Ahid S, Benhmidou N, Bellahamou K, Loughlimi H, Marnouche E, Elmajjaoui S, Elkacemi H, Kebdani T, Benjaafar N. Factors influencing diagnosis delay of advanced breast cancer in Moroccan women. BMC Cancer 2016. [PMID: 27268201 DOI: 10.1186/s12885-016-2394-y.pmid:27268201freepmc] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/16/2023] Open
Abstract
BACKGROUND Delay in the diagnosis of breast cancer in symptomatic women of 3 months or more is associated with advanced stage and low survival. We conducted this study to learn more about the extent and reasons behind diagnosis delay of advanced breast cancer in Moroccan women. METHODS A group of patients with advanced breast cancer were interviewed at the National Institute of Oncology in Rabat during the period from February to December 2014. Diagnosis delay was devised into patient delay and system delay. Patient delay was defined as time from first symptoms until first medical consultation. System delay was defined as time from first presentation to a health care provider until definite diagnosis or treatment. Prospective information and clinical data were collected on a form during an interview with each patient and from medical records. RESULTS In all, 137 patients were interviewed. The mean age of women was 48.3 ± 10.4 years. The median of consultation time was 6[4,12] months and the median of diagnosis time was 1[1,3] months. Diagnosis delay was associated to a personal reason in 96 (70.1 %) patients and to a medical reason in 19 (13.9 %) patients. A number of factors predicted diagnosis delay: symptoms were not considered serious in 66 (55.9 %) patients; traditional therapy was applied in 15 (12.7 %) patients and fear of cancer diagnosis and/or treatment in 14 (11.9 %) patients. A use of traditional methods was significantly associated with rural residence and far away from basic health center (p = 0.000). Paradoxically, a family history of breast cancer was significantly higher in who report a fear of cancer diagnosis and/or treatment to diagnosis delay (p < 0.001). Also, a significantly higher risk of more than 6 months delay was found among rural women (P = 0.035) and women who live far away from specialized care center (P = 0.001). CONCLUSIONS Diagnosis delay is very serious problem in Morocco. Diagnosis delay was associated with complex interactions between several factors and with advanced stages. There is a need for improving breast cancer information in our populations and training of general practitioners to reduce advanced breast cancer by promoting early detection.
Collapse
Affiliation(s)
- A Maghous
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco.
| | - F Rais
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - S Ahid
- Laboratory of epidemiology and clinical research, School of medicine and pharmacy of Rabat, Mohammed V University in Rabat, Rabat, Morocco
| | - N Benhmidou
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - K Bellahamou
- Department of Medical Oncology, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - H Loughlimi
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - E Marnouche
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - S Elmajjaoui
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - H Elkacemi
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - T Kebdani
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - N Benjaafar
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| |
Collapse
|
20
|
Maghous A, Rais F, Ahid S, Benhmidou N, Bellahamou K, Loughlimi H, Marnouche E, Elmajjaoui S, Elkacemi H, Kebdani T, Benjaafar N. Factors influencing diagnosis delay of advanced breast cancer in Moroccan women. BMC Cancer 2016; 16:356. [PMID: 27268201 PMCID: PMC4897875 DOI: 10.1186/s12885-016-2394-y] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2015] [Accepted: 06/02/2016] [Indexed: 01/07/2023] Open
Abstract
BACKGROUND Delay in the diagnosis of breast cancer in symptomatic women of 3 months or more is associated with advanced stage and low survival. We conducted this study to learn more about the extent and reasons behind diagnosis delay of advanced breast cancer in Moroccan women. METHODS A group of patients with advanced breast cancer were interviewed at the National Institute of Oncology in Rabat during the period from February to December 2014. Diagnosis delay was devised into patient delay and system delay. Patient delay was defined as time from first symptoms until first medical consultation. System delay was defined as time from first presentation to a health care provider until definite diagnosis or treatment. Prospective information and clinical data were collected on a form during an interview with each patient and from medical records. RESULTS In all, 137 patients were interviewed. The mean age of women was 48.3 ± 10.4 years. The median of consultation time was 6[4,12] months and the median of diagnosis time was 1[1,3] months. Diagnosis delay was associated to a personal reason in 96 (70.1 %) patients and to a medical reason in 19 (13.9 %) patients. A number of factors predicted diagnosis delay: symptoms were not considered serious in 66 (55.9 %) patients; traditional therapy was applied in 15 (12.7 %) patients and fear of cancer diagnosis and/or treatment in 14 (11.9 %) patients. A use of traditional methods was significantly associated with rural residence and far away from basic health center (p = 0.000). Paradoxically, a family history of breast cancer was significantly higher in who report a fear of cancer diagnosis and/or treatment to diagnosis delay (p < 0.001). Also, a significantly higher risk of more than 6 months delay was found among rural women (P = 0.035) and women who live far away from specialized care center (P = 0.001). CONCLUSIONS Diagnosis delay is very serious problem in Morocco. Diagnosis delay was associated with complex interactions between several factors and with advanced stages. There is a need for improving breast cancer information in our populations and training of general practitioners to reduce advanced breast cancer by promoting early detection.
Collapse
Affiliation(s)
- A Maghous
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco.
| | - F Rais
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - S Ahid
- Laboratory of epidemiology and clinical research, School of medicine and pharmacy of Rabat, Mohammed V University in Rabat, Rabat, Morocco
| | - N Benhmidou
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - K Bellahamou
- Department of Medical Oncology, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - H Loughlimi
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - E Marnouche
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - S Elmajjaoui
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - H Elkacemi
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - T Kebdani
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| | - N Benjaafar
- Department of radiotherapy, National Institute of Oncology, Mohammed V University in Rabat, Rabat, Morocco
| |
Collapse
|
21
|
Bellefqih S, Hadadi K, Mezouri I, Maghous A, Marnouche E, Andaloussi K, Elmarjany M, Sifat H, Mansouri H, Benjaafar N. Association de radiothérapie et d’hormonothérapie dans la prise en charge des cancers localisés de la prostate : où en est-on ? Cancer Radiother 2016; 20:141-50. [DOI: 10.1016/j.canrad.2015.12.002] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2015] [Revised: 12/21/2015] [Accepted: 12/24/2015] [Indexed: 12/12/2022]
|
22
|
Bellefqih S, Hadadi K, Mezouri I, Maghous A, Marnouche E, Andaloussi K, Elmarjany M, Sifat H, Mansouri H, Benjaafar N. Association de radiothérapie et d’hormonothérapie dans la prise en charge des cancers localisés de la prostate : où en est-on ? Cancer Radiother 2016. [DOI: 10.1016/j.canrad.2016.02.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
23
|
Bellefqih S, Hadadi K, Mezouri I, Maghous A, Marnouche E, Andaloussi K, Elmarjany M, Sifat H, Mansouri H, Benjaafar N. Association de radiothérapie et d’hormonothérapie dans la prise en charge des cancers localisés de la prostate : où en est-on ? Cancer Radiother 2016. [DOI: 10.1016/j.canrad.2016.02.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
24
|
Khalil J, Elomrani F, Benoulaid M, Elkacemi H, Kebdani T, Errihani H, Benjaafar N. Isolated thyroid metastasis revealed an unknown lung adenocarcinoma: a case report. J Med Case Rep 2015; 9:221. [PMID: 26410084 PMCID: PMC4584122 DOI: 10.1186/s13256-015-0663-z] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2015] [Accepted: 07/28/2015] [Indexed: 12/26/2022] Open
Abstract
INTRODUCTION Cancer metastasis to the thyroid is extremely rare. The most common sites that have been reported to metastasize to the thyroid gland are breast and kidney. As to primary lung cancer metastasizing to the thyroid gland, only a few cases have been described in the literature. CASE PRESENTATION We report a case of a 37-year-old white Arabian woman who had never smoked tobacco products for whom a malignant thyroid mass revealed a primary lung tumor. She had a surgical excision for both the thyroid and the pulmonary tumors, and received adjuvant chemotherapy. At 1 year, she is still in remission. CONCLUSIONS Our case is rare as it describes a case where the thyroid lesion was the revealing sign of an unknown lung carcinoma. Management of thyroid metastases should depend on the individual situation and surgical excision should be proposed whenever a patient's condition is favorable.
Collapse
Affiliation(s)
- J Khalil
- Radiation oncology department, National Institute of oncology, Mohamed V University, Rabat, Morocco.
| | - F Elomrani
- Medical oncology department, Mohamed V University, Rabat, Morocco.
| | - M Benoulaid
- Radiation oncology department, National Institute of oncology, Mohamed V University, Rabat, Morocco.
| | - H Elkacemi
- Radiation oncology department, National Institute of oncology, Mohamed V University, Rabat, Morocco
| | - T Kebdani
- Radiation oncology department, National Institute of oncology, Mohamed V University, Rabat, Morocco
| | - H Errihani
- Medical oncology department, Mohamed V University, Rabat, Morocco
| | - N Benjaafar
- Radiation oncology department, National Institute of oncology, Mohamed V University, Rabat, Morocco
| |
Collapse
|
25
|
Khalil J, Bellefqih S, Sahli N, Afif M, Elkacemi H, Elmajjaoui S, Kebdani T, Benjaafar N. Impact of cervical cancer on quality of life: beyond the short term (Results from a single institution): Quality of life in long-term cervical cancer survivors: results from a single institution. Gynecol Oncol Res Pract 2015; 2:7. [PMID: 27231567 PMCID: PMC4880873 DOI: 10.1186/s40661-015-0011-4] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/09/2015] [Accepted: 08/14/2015] [Indexed: 11/30/2022]
Abstract
Background Cervical cancer (CC) is one of the most widespread gynecological malignancies in women worldwide. Treatment strategies and screening modalities have largely evolved these past years resulting in an improvement of survival. However, treatment modalities are associated with long term side effects that significantly impacts quality of life (QOL) in cervical cancer survivors. The aim of this study is to evaluate QOL (General and sexual QOL) in cervical cancer survivors up to 10 years after the diagnosis. Material and methods In a cross-sectional descriptive study design, 110 cervical cancer survivors (CCS) and 80 healthy controls completed questionnaires assessing QOL. Results Participants were Arabic White, sexually active. The mean age at diagnosis was 34 years and was 43 years at the time of the interview. In our series long term CCS have generally a good global QOL comparable with healthy controls. However, issues concerning emotional functioning were over expressed by CCS. As to the sexual impact of cervical cancer; CCS experienced less sexual functioning and enjoyment and less satisfaction with their body image when compared to healthy controls. In a multivariate analysis, spiritual well-being and social support were the predictor factors that statistically affected QOL among the studied cohort, it accounted for 81 % of the variance in QOL scores. Conclusions A better understanding of the complexity of the relationship between QOL and cervical cancer sequelae in one hand and socio-demographic factors in the other hand is necessary to improve QOL among cervical cancer survivors. More efforts should make to inform disease free patients about expected side effects and symptoms to face the physical changes that would affect their QOL and sexual activity.
Collapse
Affiliation(s)
- J Khalil
- National cancer Institute, Mohamed V University, Rabat, Morocco
| | - S Bellefqih
- National cancer Institute, Mohamed V University, Rabat, Morocco
| | - N Sahli
- National cancer Institute, Mohamed V University, Rabat, Morocco
| | - M Afif
- National cancer Institute, Mohamed V University, Rabat, Morocco
| | - H Elkacemi
- National cancer Institute, Mohamed V University, Rabat, Morocco
| | - S Elmajjaoui
- National cancer Institute, Mohamed V University, Rabat, Morocco
| | - T Kebdani
- National cancer Institute, Mohamed V University, Rabat, Morocco
| | - N Benjaafar
- National cancer Institute, Mohamed V University, Rabat, Morocco
| |
Collapse
|
26
|
Khalil J, Elkacemi H, Sahli N, El Omrani F, Kebdani T, Benjaafar N. 2730 Quality of life in long-term cervical cancer survivors: Results from a single institution. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31497-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
27
|
Saadi A, Tazi M, Er-raki A, Benjaafar N, Bennani Mechida N, Mrabet M, Razine R. Analyse de survie au cancer du col de l’utérus à Rabat (Maroc) de 2005 à 2008. Rev Epidemiol Sante Publique 2015. [DOI: 10.1016/j.respe.2015.03.107] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
28
|
Khalil J, Bellefqih S, Afif M, Elkacemi H, Kebdani T, Benjaafar N. Prognostic factors affecting cervical adenocarcinoma: 10 years experience in a single institution. Arch Gynecol Obstet 2015; 292:915-21. [DOI: 10.1007/s00404-015-3701-6] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2015] [Accepted: 03/24/2015] [Indexed: 11/28/2022]
|
29
|
Bellefqih S, Mezouri I, Khalil J, Bazine A, Diakité A, El Kacimi H, Kebdani T, Benjaafar N. [Primary central nervous lymphoma: what is the role for radiotherapy?]. Cancer Radiother 2014; 18:685-92. [PMID: 25451676 DOI: 10.1016/j.canrad.2014.06.025] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2014] [Revised: 05/23/2014] [Accepted: 06/06/2014] [Indexed: 10/24/2022]
Abstract
Primary central nervous system lymphoma is a rare extranodal form of non-Hodgkin lymphoma with an aggressive course and unsatisfactory outcome. Historically, whole-brain radiotherapy was the sole treatment for patients with primary central nervous system lymphoma, with high response rates but typically, this did not result in long-lasting remissions. The addition of high-dose methotrexate-based chemotherapy regimens to whole-brain radiotherapy has significantly improved patients' outcome, but has resulted in a higher incidence of late neurotoxicity, particularly in elderly patients. To date, the role of consolidation radiotherapy is controversial, and some investigators have developed alternative strategies aiming at avoiding immediate irradiation or using a reduced radiotherapy dose to the whole-brain with promising results.
Collapse
Affiliation(s)
- S Bellefqih
- Service de radiothérapie, Institut national d'oncologie, avenue Allal El-Fassi, 10100 Rabat, Maroc; Université Mohammed-V Souissi, 10100 Rabat, Maroc.
| | - I Mezouri
- Service de radiothérapie, Institut national d'oncologie, avenue Allal El-Fassi, 10100 Rabat, Maroc; Université Mohammed-V Souissi, 10100 Rabat, Maroc
| | - J Khalil
- Service de radiothérapie, Institut national d'oncologie, avenue Allal El-Fassi, 10100 Rabat, Maroc; Université Mohammed-V Souissi, 10100 Rabat, Maroc
| | - A Bazine
- Service de radiothérapie, Institut national d'oncologie, avenue Allal El-Fassi, 10100 Rabat, Maroc; Université Mohammed-V Souissi, 10100 Rabat, Maroc
| | - A Diakité
- Service de radiothérapie, Institut national d'oncologie, avenue Allal El-Fassi, 10100 Rabat, Maroc; Université Mohammed-V Souissi, 10100 Rabat, Maroc
| | - H El Kacimi
- Service de radiothérapie, Institut national d'oncologie, avenue Allal El-Fassi, 10100 Rabat, Maroc; Université Mohammed-V Souissi, 10100 Rabat, Maroc
| | - T Kebdani
- Service de radiothérapie, Institut national d'oncologie, avenue Allal El-Fassi, 10100 Rabat, Maroc; Université Mohammed-V Souissi, 10100 Rabat, Maroc
| | - N Benjaafar
- Service de radiothérapie, Institut national d'oncologie, avenue Allal El-Fassi, 10100 Rabat, Maroc; Université Mohammed-V Souissi, 10100 Rabat, Maroc
| |
Collapse
|
30
|
Bellefqih S, Khalil J, Mezouri I, ElKacemi H, Kebdani T, Hadadi K, Benjaafar N. [Concomitant chemoradiotherapy for muscle-invasive bladder cancer: current knowledge, controversies and future directions]. Cancer Radiother 2014; 18:779-89. [PMID: 25454383 DOI: 10.1016/j.canrad.2014.08.006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2014] [Revised: 07/23/2014] [Accepted: 08/06/2014] [Indexed: 01/04/2023]
Abstract
Radical cystectomy with lymphadenectomy is currently the standard of care for muscle-invasive urothelial bladder cancer; however and because of its morbidity and its impact on quality of life, there is a growing tendency for bladder-sparing strategies. Initially reserved for elderly or unfit patients unable to undergo radical cystectomy, chemoradiotherapy became a true alternative to surgery for highly selected patients. Although there are no randomized trials comparing radical cystectomy with bladder preserving approaches, surgery remains the preferred treatment for many clinicians. Furthermore, comparison is even more difficult as modalities of radiotherapy are not consensual and differ between centers with a variability of protocols, volume of irradiation and type of chemotherapy. Several ongoing trials are attempting to optimize chemoradiotherapy and limit its toxicity, especially through techniques of adaptive radiotherapy or targeted therapies.
Collapse
Affiliation(s)
- S Bellefqih
- Service de radiothérapie, Institut national d'oncologie, université Mohammed-V Souissi, avenue Allal-El Fassi, 10100 Rabat, Maroc.
| | - J Khalil
- Service de radiothérapie, Institut national d'oncologie, université Mohammed-V Souissi, avenue Allal-El Fassi, 10100 Rabat, Maroc
| | - I Mezouri
- Service de radiothérapie, Institut national d'oncologie, université Mohammed-V Souissi, avenue Allal-El Fassi, 10100 Rabat, Maroc
| | - H ElKacemi
- Service de radiothérapie, Institut national d'oncologie, université Mohammed-V Souissi, avenue Allal-El Fassi, 10100 Rabat, Maroc
| | - T Kebdani
- Service de radiothérapie, Institut national d'oncologie, université Mohammed-V Souissi, avenue Allal-El Fassi, 10100 Rabat, Maroc
| | - K Hadadi
- Service de radiothérapie, hôpital militaire d'instruction Mohamed-V, 10100 Rabat, Maroc
| | - N Benjaafar
- Service de radiothérapie, Institut national d'oncologie, université Mohammed-V Souissi, avenue Allal-El Fassi, 10100 Rabat, Maroc
| |
Collapse
|
31
|
Bellefqih S, Khalil J, Mezouri I, Afif M, Elmajjaoui S, Kebdani T, Benjaafar N. [Superior vena cava syndrome with malignant causes]. Rev Pneumol Clin 2014; 70:343-352. [PMID: 25457217 DOI: 10.1016/j.pneumo.2014.08.001] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/05/2014] [Revised: 08/11/2014] [Accepted: 08/17/2014] [Indexed: 06/04/2023]
Abstract
Superior vena cava syndrome comprises various symptoms and signs resulting from the obstruction of the superior vena cava and resulting in reduced blood flow. Superior vena cava may occur secondary to a variety of conditions, but malignant etiologies are the most common. Usually, the diagnosis is based on a quite clear clinical presentation. Patient with acute presentation can develop life-threatening complications such as cerebral or laryngeal edema. In the absence of these two conditions, a histologic diagnosis should be obtained before the initiation of any therapy. Management of superior vena cava syndrome requires a multidisciplinary team. Therapeutic approaches include radiotherapy, chemotherapy and endovascular approach, and the choice of therapy will depend on the severity of the symptoms, the type and the stage of the tumor, but also the patient's general condition.
Collapse
Affiliation(s)
- S Bellefqih
- Service de radiothérapie, institut national d'oncologie, université Mohammed-V Souissi, avenue Allal-El Fassi, 10100 Rabat, Maroc.
| | - J Khalil
- Service de radiothérapie, institut national d'oncologie, université Mohammed-V Souissi, avenue Allal-El Fassi, 10100 Rabat, Maroc
| | - I Mezouri
- Service de radiothérapie, institut national d'oncologie, université Mohammed-V Souissi, avenue Allal-El Fassi, 10100 Rabat, Maroc
| | - M Afif
- Service de radiothérapie, institut national d'oncologie, université Mohammed-V Souissi, avenue Allal-El Fassi, 10100 Rabat, Maroc
| | - S Elmajjaoui
- Service de radiothérapie, institut national d'oncologie, université Mohammed-V Souissi, avenue Allal-El Fassi, 10100 Rabat, Maroc
| | - T Kebdani
- Service de radiothérapie, institut national d'oncologie, université Mohammed-V Souissi, avenue Allal-El Fassi, 10100 Rabat, Maroc
| | - N Benjaafar
- Service de radiothérapie, institut national d'oncologie, université Mohammed-V Souissi, avenue Allal-El Fassi, 10100 Rabat, Maroc
| |
Collapse
|
32
|
Bellefqih S, Khalil J, Mezouri I, ElKacemi H, Kebdani T, Hadadi K, Benjaafar N. Chimioradiothérapie concomitante des tumeurs infiltrantes de la vessie : acquis, controverses et perspectives. Cancer Radiother 2014. [DOI: 10.1016/j.canrad.2014.10.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
33
|
Bellefqih S, Khalil J, Mezouri I, ElKacimi H, Kebdani T, Hadadi K, Benjaafar N. Chimioradiothérapie concomitante des tumeurs infiltrantes de la vessie : acquis, controverses et perspectives. Cancer Radiother 2014. [DOI: 10.1016/j.canrad.2014.10.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
34
|
Mouhajir N, Diakité A, Toulba A, Hemmich M, Saadi I, Elkacemi H, Kebdani T, Benjaafar N. Primary Non-Hodgkin's Lymphoma of the Uterine Cervix: Case Report of Long-Term Survival Patient. J Obstet Gynaecol India 2014; 64:145-7. [PMID: 25404844 DOI: 10.1007/s13224-013-0483-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2013] [Accepted: 10/14/2013] [Indexed: 11/25/2022] Open
Affiliation(s)
- N Mouhajir
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - A Diakité
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - A Toulba
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - M Hemmich
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - I Saadi
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - H Elkacemi
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - T Kebdani
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| | - N Benjaafar
- Department of Radiotherapy, National Institute of Oncology, Rabat, Morocco
| |
Collapse
|
35
|
Bellefqih S, Mezouri I, Khalil J, Bazine A, Diakité A, El Kacimi H, Kebdani T, Benjaafar N. Lymphome primitif du système nerveux central : quel rôle pour la radiothérapie ? Cancer Radiother 2014. [DOI: 10.1016/j.canrad.2014.09.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
36
|
Bellefqih S, Mezouri I, Khalil J, Bazine A, Diakité A, Kacimi HE, Kebdani T, Benjaafar N. Lymphome primitif du système nerveux central : quel rôle pour la radiothérapie ? Cancer Radiother 2014. [DOI: 10.1016/j.canrad.2014.09.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
37
|
Diakité A, Bakkali H, Tolba A, Mariem H, Mouhajir N, Diabaté K, Nouh M, N’koua B, Boutayeb S, Kebdani T, Elgueddari BK, Ahid S, Benjaafar N. Curiethérapie à haute dose dans le cancer du col utérin : utilisation de l’applicateur en anneau. ACTA ACUST UNITED AC 2014. [DOI: 10.1007/s12558-014-0330-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
38
|
Bellefqih S, Khalil J, Mezouri I, Kebdani T, Benjaafar N. [Small cell neuroendocrine carcinoma of the uterine cervix: Report of six cases and a review of the literature]. Cancer Radiother 2014; 18:201-7. [PMID: 24656987 DOI: 10.1016/j.canrad.2014.01.003] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2013] [Revised: 01/16/2014] [Accepted: 01/30/2014] [Indexed: 11/19/2022]
Abstract
Neuroendocrine carcinoma is a rare and aggressive malignant tumour, mainly developing at the expense of the respiratory and of the digestive tract. Gynecological neuroendocrine tumours are rare and small cell neuroendocrine tumours of the uterine cervix represent 2% of cervical cancer. Given their rarity and the lack of randomized trials, the diagnostic and therapeutic management of these tumors is difficult and essentially based on that of pulmonary neuroendocrine tumours. Like the latter, and despite multimodality regimens, the prognosis of these tumours remains poor. Through this series, we report our experience in the management of these particular tumours while comparing our data with those of the literature.
Collapse
Affiliation(s)
- S Bellefqih
- Service de radiothérapie, Institut national d'oncologie, avenue Allal-El Fassi, 10100 Rabat, Maroc.
| | - J Khalil
- Service de radiothérapie, Institut national d'oncologie, avenue Allal-El Fassi, 10100 Rabat, Maroc
| | - I Mezouri
- Service de radiothérapie, Institut national d'oncologie, avenue Allal-El Fassi, 10100 Rabat, Maroc
| | - T Kebdani
- Service de radiothérapie, Institut national d'oncologie, avenue Allal-El Fassi, 10100 Rabat, Maroc
| | - N Benjaafar
- Service de radiothérapie, Institut national d'oncologie, avenue Allal-El Fassi, 10100 Rabat, Maroc
| |
Collapse
|
39
|
Lachgar A, Diakité A, Kebdani T, El Gueddari B, Benjaafar N. Exacerbation de la douleur après radiothérapie antalgique de métastases osseuses. Cancer Radiother 2013. [DOI: 10.1016/j.canrad.2013.07.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
40
|
Diakité A, Bakkali H, Kebdani T, Benjaafar N. Curiethérapie de haut débit de dose dans le cancer du col utérin : utilisation de l’applicateur en anneau, à propos de 105 cas. Cancer Radiother 2013. [DOI: 10.1016/j.canrad.2013.07.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
41
|
Lachgar A, Afif M, Kebdani T, El Gueddari B, Benjaafar N. Résultats thérapeutiques de 33 patients atteints d’un cancer du nasopharynx avec atteinte des nerfs crâniens. Cancer Radiother 2013. [DOI: 10.1016/j.canrad.2013.07.131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
42
|
Raissouni S, Rais G, Lkhoyaali S, Aitelhaj M, Mouzount H, Mokrim M, Razine R, El Kacemi H, Mrabti H, Benjaafar N, Errihani H. Clinical prognostic factors in locally advanced nasopharyngeal carcinoma in Moroccan population. Gulf J Oncolog 2013; 1:35-44. [PMID: 23996865] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/07/2013] [Indexed: 06/02/2023]
Abstract
BACKGROUND Nasopharyngeal carcinoma is a distinct cancer of head and neck by its pathology, etiology, epidemiology and clinical behavior. Morocco is considered an endemic region with intermediate incidence. The aim of our report is to underline some clinical determinants of survival in locally advanced disease. PATIENTS AND METHODS We conducted a retrospective study from January 2003 to December 2005. All patients with undifferentiated nasopharyngeal carcinoma treated in the National Institute of Oncology of Rabat, Morocco were recorded. Classified stage II to IVB disease according to TNM classification adopted by the AJCC (American Joint Committee of Cancer) 6th edition. RESULTS The study included 339 patients, 122 women and 217 men (sex-ratio: 1.7). Mean age was 43 years old (range: 6-91years). Median duration to diagnosis was 6 months (range: 1-72) presenting symptoms at diagnosis were predominantly cervical lymph node in 79%. Forty- two patients have T1 tumors, 159 = T2 tumors, 64 = T3 tumors and 69 = T4 tumors. Sixty-five patients do not have lymph-node involvement, 49 have N1, 128 have N2 and 95 have N3. Three patients were at stage IIA, 57 patients were at stage IIB, 40 patients were at stage III, and 57 patients were at stage IVA and the remaining 96 patients were at stage IVB. Eighty-seven percent of patients underwent sequential chemoradiation and 17% underwent concurrent chemo-radiation (CTR). Response to induction chemotherapy was assessed in 235 patients. There were 31 patients with complete response and 59 patients have partial response. Complete response to radiotherapy was reached in 235 patients. Mean overall survival (OS) was 66.2%. Gender was a prognostic factor of OS (p=0.045) and DFS favoring women. Age wasn't a prognostic factors determining the outcome with no difference between patients aged more than 40 years old and patients younger. Tumor size was not a determinant of survival with a non-significant p in OS and DFS (0.27 and 0.46 respectively) but T4 stage patients appear to have a worse prognosis. Lymph node involvement was significantly determining the outcome either in OS and DFS (p=0.001 and 0.009 respectively). TNM stage was also a significant prognostic factor in OS but not in DFS favoring those with early stage (p= 0, 004 and p= 0, 13 respectively). The treatment strategy was not a significant prognostic factor with no difference between patients who underwent sequential or concurrent chemoradiation (OS p= 0, 48 and DFS p= 0, 9). In multivariate analysis, lymph-node involvement is the most significant factor. CONCLUSION Our findings were mostly concordant with the literature data in endemic areas for TNM staging; however we are limited by the bias of retrospective studies. Prospective studies would be more accurate to define those prognostic factors in our population. KEYWORDS UCNT, prognostic factors, endemic areas, lymph node involvement.
Collapse
Affiliation(s)
- S Raissouni
- Soundouss Raissouni, M.D., Medical Oncology Department, National Institute of Oncology, Raba, Morocco.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Belbaraka R, Lalya I, Boulaamane L, Tazi M, Benjaafar N, Errihani H. [Dietary risk factors of undifferenced nasopharyngeal carcinoma : a case-control study]. Tunis Med 2013; 91:406-409. [PMID: 23868040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
Abstract
BACKGROUND The incidence of nasopharyngeal carcinoma (NPC) is relatively high in Maghreb countries. This cancer is a model of multifactorial oncogenesis, but the role of food as risk factor in ethiopathogenesis of this tumor is not negligible. AIM To identify the association between risk of NPC and some dietary factors in Morocco. METHODS It is a case-control study including all new cases of NPC in our department between December 2009 and May 2010. Frequency consummation of foods was compared between cases and controls matched for age, sex and socio economic level. A high frequency consummation of a food was defined as consumption once or more by a week. Some traditional foods in Moroccan cooking like Harissa (hot red pepper), Qadid (mutton dried and salted), Khlii (dried meat, salted, spiced cooked and preserved in a mixture of oil and rendered beef fat) and Smen (rancid butter) were analyzed in this study. A conditional logistic regression was used to identify the association between dietary factors and the risk of NPC. RESULTS Cases were more likely to have high frequency consumption of Harissa, Smen and Black Pepper, and less frequency consumption of fruts and vegetables. There was significant association between the risk of NPC and the frequency consumption of Qadid, khlii and cooking with olive oil. CONCLUSIONS Some of these risk factors (Harissa, Black pepper) were found in 3 North Africain studies. This study indicates the involvement of dietary factors, and thus the lifestyle in the development of NPC and the need of biochemical analysis of food specimens to search for the carcinogenic agents.
Collapse
|
44
|
Zaidi H, Berhil H, Chenna H, Mouhajir N, El Majjaoui S, El Kacemi H, Hassouni K, Kebdani T, El Gueddari B, Benjaafar N. Cancers primitifs invasifs de la vulve : expérience de l’Institut national d’oncologie de Rabat. Cancer Radiother 2012. [DOI: 10.1016/j.canrad.2012.07.133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
45
|
Kabbali N, Himmich M, Kebdani T, Hassouni K, El Gueddari B, Benjaafar N. Place de la radiothérapie exclusive dans les paragangliomes non opérables de la tête et du cou, à propos d’une série de dix cas. Cancer Radiother 2012. [DOI: 10.1016/j.canrad.2012.07.163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
46
|
Bellefqih S, Khalil J, Mezouri I, Lalya I, Afif M, Jnah L, Hassouni K, Kebdani T, Benjaafar N. Carcinome à cellules indépendantes du rectum : à propos de 16 cas. Cancer Radiother 2012. [DOI: 10.1016/j.canrad.2012.07.111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
47
|
Chenna H, Nouni K, Berhil H, Zaidi H, El Kacemi H, Hassouni K, Kebdani T, El Gueddari B, Benjaafar N. Cancer du canal anal : expérience de l’Institut national d’oncologie de Rabat, à propos de 110 cas. Cancer Radiother 2012. [DOI: 10.1016/j.canrad.2012.07.109] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
48
|
Mouhajir N, Hemmich M, Elmajjaoui S, Tolba A, Berhil H, Rami K, Kebdani T, Benjaafar N. Apport de la curiethérapie interstitielle dans le traitement conservateur du cancer du sein : à propos de 38 cas. Cancer Radiother 2012. [DOI: 10.1016/j.canrad.2012.07.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
49
|
Khalil J, Lalya I, Afif M, Bellefqui S, Kebdani T, Hassouni K, Gueddari B, Benjaafar N. Sexualité après un cancer du sein : quel impact ? (Expérience marocaine). Cancer Radiother 2012. [DOI: 10.1016/j.canrad.2012.07.078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
50
|
Lachgar A, Diabate K, Khalil J, Hassouni K, Kebdani T, Elgueddari B, Benjaafar N. Traitement antalgique des métastases osseuses symptomatiques par irradiation externe. Cancer Radiother 2012. [DOI: 10.1016/j.canrad.2012.07.083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|